Medicine and Dentistry
Central Retinal Vein Occlusion
100%
Branch Retinal Vein Occlusion
67%
Intravitreal Implant
65%
Proteome Analysis
65%
Aflibercept
65%
Upregulation
39%
Retina Vein Occlusion
32%
Caveolin 1
32%
Platelet Derived Growth Factor Receptor
32%
Subgroup Analysis
32%
Von Hippel-Lindau Disease
32%
Hemangioblastoma
32%
Arm
32%
Prothrombin
32%
Implant
17%
Macular Edema
15%
Liquid Chromatography-Mass Spectrometry
13%
Immunohistochemistry
12%
Proteomics
11%
Salt Water
10%
Vasculotropin
10%
Mass Spectrum
9%
Tandem Mass Tag
9%
Disease Exacerbation
9%
Western Blot
8%
Label-Free Quantification
7%
Peptidylprolyl Isomerase
6%
Vasculotropin Receptor 2
6%
Heat Shock Protein
6%
Tandem Mass Spectrometry
6%
Intravitreal Administration
6%
down Regulation
6%
Neuroscience
Retinal Vein Occlusion
97%
Central Retinal Vein
65%
Bevacizumab
65%
Interleukin 18
32%
Focal Adhesion
32%
Aflibercept
32%
Vitronectin
16%
Chemical Synapse
16%
Annexin
16%
Cellular Stress Response
16%
Visual Phototransduction
16%
Vascular Endothelial Growth Factor
11%
Immunohistochemistry
9%
Laminin
9%
Actinin
9%
Ischemia
8%
Angiography
5%
Western Blotting
5%
Angiography
5%
Keyphrases
Intravitreal Bevacizumab
32%
Subfamily C
32%
DnaJ
32%
Caveolin-1 (Cav-1)
32%
Focal Adhesion Pathway
32%
Dexamethasone Intravitreal Implant
32%
S100A12
32%
Hypoxia-inducible Factor 2
32%
Dexamethasone Implant
20%
Actinin-1
9%
Integrin
9%
Laminin
9%
Nucleobindin-2
7%
Lambda Chains
7%
NDRG1
6%
1,2-Diols
6%
Trans-1
6%
Dihydrodiol Dehydrogenase
6%
Ubiquilin
6%
